It seems likely that blocking the GCN2 pathway may rather overactivate PERK-eIF2α signaling and exacerbate BACE1/ATF4 elevations under ER stress conditions with β-amyloidosis, although further study is needed to understand the precise mechanisms underlying interactions between these pathways in AD. The gene discussed is ATF4; the disease is Alzheimer disease.